Angiotensin II type 2 receptor agonist directly inhibits proximal tubule sodium pump activity in obese but not in lean Zucker rats

Hypertension
Amer C Hakam, Tahir Hussain

Abstract

We have reported recently that the renal angiotensin II type 2 (AT2) receptors are upregulated and involved in promoting natriuresis/diuresis in obese but not in lean Zucker rats. In the present study, we tested the hypothesis that there is an enhanced AT2 receptor signaling via NO/cGMP pathway leading to greater inhibition of the Na(+), K(+)-ATPase (NKA) activity in the proximal tubules (PT) of obese rather than lean Zucker rats. The AT2 agonist CGP42112 (0.1 to 100 nmol/L) inhibited (33% at 100 nmol/L) the NKA activity in the PTs of obese but not in lean Zucker rats. The AT2 antagonist PD123319 (1 micromol/L), not the angiotensin II type 1 antagonist losartan (1 micromol/L), significantly diminished the CGP42112-induced inhibition of the NKA activity in obese rats. The AT2 agonist (10 nmol/L)-induced NKA inhibition was abolished by the soluble guanylate cyclase inhibitor 1H-[1,2,4] oxadiazolo-[4,3-a] quinoxalin-1-one (10 micromol/L), the NO synthase inhibitor NG-nitro-L-arginine methyl ester (100 micromol/L), and the protein kinase G inhibitor K1388 (2 micromole/L). CGP42112 (10 nmol/L) caused an increase in serine phosphorylation of NKA alpha1-subunit in PT of obese rats. Measurement of cGMP and NO revealed that CGP42112 (0....Continue Reading

References

Feb 1, 1992·The American Journal of Physiology·C P Ribeiro, L J Mandel
Apr 1, 1991·Journal of the American Society of Nephrology : JASN·J L Garvin
Nov 1, 1990·British Journal of Pharmacology·D D ReesS Moncada
Apr 1, 1969·Biochimica Et Biophysica Acta·J P Quigley, G S Gotterer
Dec 6, 1994·Proceedings of the National Academy of Sciences of the United States of America·M McKeeJ A Nathanson
May 1, 1995·The Journal of Clinical Investigation·N J GuzmanL C Garg
Mar 1, 1993·Hypertension·C ChenM F Lokhandwala
Nov 1, 1996·The American Journal of Physiology·A Ferrer-MartínezM Pastor-Anglada
Mar 11, 1998·Clinical and Experimental Pharmacology & Physiology·J E HallE W Shek
Jun 2, 1998·Clinical and Experimental Hypertension : CHE·M BharatulaM F Lokhandwala
Jul 8, 1999·Regulatory Peptides·L J MillattH M Siragy
Sep 14, 1999·The American Journal of Physiology·N MiyataA W Cowley
Feb 26, 2000·Acta Physiologica Scandinavica·R M CareyH M Siragy
Feb 7, 2001·Journal of the American Society of Nephrology : JASN·Mohammad AsgharMustafa F Lokhandwala
Jan 14, 2003·Arteriosclerosis, Thrombosis, and Vascular Biology·Chen YanBradford C Berk
Feb 25, 2003·Clinical and Experimental Hypertension : CHE·Misti BeckerTahir Hussain
Dec 3, 2003·Clinical and Experimental Hypertension : CHE·Aditi Marwaha, Mustafa F Lokhandwala
Oct 6, 2005·American Journal of Physiology. Renal Physiology·Amer C HakamTahir Hussain
Dec 16, 2005·The American Journal of the Medical Sciences·Stephen A MorseEfrain Reisin
Dec 29, 2005·American Journal of Physiology. Renal Physiology·Amer C Hakam, Tahir Hussain

❮ Previous
Next ❯

Citations

Sep 6, 2012·Pflügers Archiv : European journal of physiology·Shetal H Padia, Robert M Carey
Oct 27, 2007·In Vitro Cellular & Developmental Biology. Animal·Philip G WoostUlrich Hopfer
Jul 16, 2009·Current Hypertension Reports·Helmy M Siragy
Feb 3, 2012·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Quaisar Ali, Tahir Hussain
Feb 18, 2012·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Lucinda M Hilliard, Kate M Denton
Dec 17, 2008·Current Opinion in Nephrology and Hypertension·John J Gildea
Jan 23, 2013·Clinical and Experimental Pharmacology & Physiology·Robert M Carey, Shetal H Padia
Jan 7, 2011·American Journal of Physiology. Renal Physiology·Rifat SabuhiTahir Hussain
Oct 29, 2009·Journal of the Renin-angiotensin-aldosterone System : JRAAS·Helmy M Siragy
Oct 30, 2010·Clinical and Experimental Hypertension : CHE·Linan ZhangYongli Wang
Apr 7, 2009·Regulatory Peptides·Flavia AxelbandAdalberto Vieyra
Sep 23, 2008·Pharmacology & Therapeutics·Emma S JonesRobert E Widdop
May 17, 2012·Regulatory Peptides·Silvana L Della PennaMaria I Rosón
Sep 25, 2016·American Journal of Hypertension·Robert M Carey
Nov 1, 2016·Current Opinion in Nephrology and Hypertension·Antonio A B PelusoU Muscha Steckelings
May 16, 2014·American Journal of Physiology. Renal Physiology·Glenn T NagamiOran Schachter
Aug 19, 2007·American Journal of Physiology. Heart and Circulatory Physiology·David W SteppDavid M Pollock

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.